Orasis Pharmaceuticals
Reshaping Vision Possibilities
United States
42 employees
Series C
Total: $43.00M
Health Care, Pharmaceutical
General Information
United States
BounceWatch is an independent company data service, not affiliated with Orasis Pharmaceuticals. To contact Orasis Pharmaceuticals, visit orasis-pharma.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does Orasis Pharmaceuticals compare?
A PDF of Orasis Pharmaceuticals and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting Orasis Pharmaceuticals soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
Discover More
United States Market
Health Care
About Orasis Pharmaceuticals
Business keywords: ophthalmology, presbyopia treatment, eye care, pharmaceuticals, vision enhancement, innovation, disruption, drug development, medical advancements
Funding Rounds & Investors (3)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Series C | $30.00M | 6 |
|
10 Sep 2020 |
| Series B | $13.00M | 4 |
|
05 Jun 2018 |
| Series A | Undisclosed | - |
|
01 Jan 2016 |
Orasis Pharmaceuticals Alternatives & Competitors
View All Alternatives
Through innovation in health and medical fields, we will make the world happier and healthier
Click visit website to learn more.
Innovative biotechnological advancements for targeting metabolic pathways in cancer cells.
FAQ About Orasis Pharmaceuticals
Source: BounceWatch company record for Orasis Pharmaceuticals, https://bouncewatch.com/company/orasis-pharmaceuticals, updated 30 December 2024. When citing, please name BounceWatch and link this page.
